Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Early Growth Response 4 (EGR4) Peptide

EGR4 Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5685031
  • Target See all EGR4 products
    EGR4 (Early Growth Response 4 (EGR4))
    Origin
    Human
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    EGR4 peptide corresponds to 13 amino acids of EGR4.
  • Application Notes
    EGR4 Peptide is used for blocking the activity of EGR4 antibody . The EGR4 antibody ships at 0.5 mg/mL and the EGR4 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    EGR4 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    EGR4 (Early Growth Response 4 (EGR4))
    Synonyms
    EGR4 Peptide, NGFI-C Peptide, NGFIC Peptide, PAT133 Peptide, NGF1-C Peptide, pAT133 Peptide, Egr4l1 Peptide, early growth response 4 Peptide, EGR4 Peptide, Egr4 Peptide
    Gene ID
    1961
    NCBI Accession
    NP_001956
    OMIM
    237512940
    UniProt
    Q05215
You are here:
Support